Calcineurin inhibitor-induced headache: Clinical characteristics and possible mechanisms

Headache

Volumn 45, Issue 3, 2005, Pages 211-214

  Ferrari, Uta ^a   Empl, Monika ^a   Kim, Kwang Sik ^b   Sostak, Petra ^a   Förderreuther, Stefanie ^a   Straube, Andreas ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Calcineurin inhibitors; Headache; Human cerebral endothelial cells; Immune suppression; Nitric oxide; Organ transplantation

Indexed keywords

CALCINEURIN INHIBITOR; CYCLOSPORIN; INDOMETACIN; NITRIC OXIDE; TACROLIMUS;

ADULT; AGED; ARTICLE; BRAIN CELL; CLINICAL FEATURE; CONTROLLED STUDY; DRUG INDUCED HEADACHE; ENDOTHELIUM CELL; FEMALE; GRAFT VERSUS HOST REACTION; HEADACHE; HEMICRANIA CONTINUA; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY METABOLISM; MAJOR CLINICAL STUDY; MALE; MIGRAINE WITHOUT AURA; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGED; BRAIN; CALCINEURIN; CELLS, CULTURED; CYCLOSPORINE; ENDOTHELIAL CELLS; FEMALE; HEADACHE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; NITRIC OXIDE; RETROSPECTIVE STUDIES; TACROLIMUS; TRANSPLANTS;

EID: 15344339211     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2005.05046.x     Document Type: Article

References (14)

1. Steiger MJ, Farrah T, Rolles K, Harvey P, Burroughs AK. Cyclosporine associated headache. J Neurol Neurosurg Psychiatry. 1994;57(10):1258-1259.
2. Maghrabi K, Bohlega S. Cyclosporine-induced migraine with severe vomiting causing loss of renal graft. Clin Neurol Neurosurg. 1998;100(3):224-227.
3. Reuter U, Bolay H, Jansen-Olesen I, et al. Delayed inflammation in rat meninges: implications for migraine pathophysiology. Brain. 2001;124:2490-2502.
4. Olesen J, Thomsen LL, Lassen LH, Olesen IJ. The nitric oxide hypothesis of migraine and other vascular headaches. Cephalalgia. 1995;15:94-100.
5. Lassen LH, Ashina M, Christiansen I, Ulrich V, Olesen J. Nitric oxide synthase inhibition in migraine. Lancet. 1997;349:401-402.
6. Ashina M, Lassen LH, Bendtsen L, Jensen R, Olesen J. Effect of inhibition of nitric oxide synthase on chronic tension-type headache: a randomised crossover trial. Lancet. 1999; 353.
7. Lima R, Serone AP, Schor N, Higa EMS. Effect of cyclosporin A on nitric oxide production in cultured LLC-PK1 cells. Renal Fail. 2001;23(1):43-52.
8. Stins MF, Gilles F, Kim KS. Selective expression of adhesion molecules on human brain microvascular endotheial cells. J Neuroimmunol. 1997;76:81-90.
9. Stefano GB, Salet M, Magazine HI. Cyclic nitric oxide release by human granulocytes, and invertebrate ganglia and immunocytes: nano-technological enhancement of amperometric nitric oxide determination. Med Sci Monit. 2002;8(6):199-204.
10. Pichlmayer R, Winkler M, Neuhaus P, et al. Three years follow-up of the European multicenter tacrolimus (FK 506) liver study. Transplant Proc. 1997;29:2499-2502.
11. Esch T, Stefano GB, Fricchione GL, Benson H. Stress-related disease-a potential role for nitric oxide. Med Sci Monit. 2002;8(6):103-118.
12. Gryn J, Goldberg J, Viner E. Propranolol for the treatment of cyclosporine-induced headaches. Bone Marrow Transplant. 1992;9:211-202.
13. Rozen TD, Wijdicks EF, Hay JE. Treatment-refractory cyclosporine- associated headache: relief with conversion to FK-506. Neurology. 1996;47(5): 1347.
14. Grotz WH, Breitenfeld MK, Braune SW, et al. Calcineurin-inhibitor induced pain syndrome (CIPS): a severe disabling complication after organ transplantation. Transpl Int. 2001;14:16-23.